Residual C‐peptide in type 1 diabetes: what do we really know? - VanBuecken - 2014 - Pediatric Diabetes - Wiley Online Library
Studienlage - Lässt sich die Zerstörung der insulinproduzierenden Betazellen aufhalten?
Type 1 diabetes - The Lancet
View of Alpha cell function in type 1 diabetes | British Journal of Diabetes
Should anti-glutamic acid decarboxylase antibody levels be determined in new-onset diabetes? - Endocrine Practice
Adult-onset type 1 diabetes: A changing perspective - ScienceDirect
C-Peptid - Übersicht
Persistent C-peptide secretion in Type 1 diabetes and its relationship to the genetic architecture of diabetes | BMC Medicine | Full Text
![PDF] Effect of interactions between C peptide levels and insulin treatment on clinical outcomes among patients with type 2 diabetes mellitus | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/6703449dea9052c1410cc7d2bcc59af7ded9d47d/3-Figure1-1.png "PDF] Effect of interactions between C peptide levels and insulin treatment on clinical outcomes among patients with type 2 diabetes mellitus | Semantic Scholar")
PDF] Effect of interactions between C peptide levels and insulin treatment on clinical outcomes among patients with type 2 diabetes mellitus | Semantic Scholar
Pathological events leading to type 1 and type 2 diabetes mellitus. The... | Download Scientific Diagram
Pharmaceutics | Free Full-Text | N-3 PUFA and Pregnancy Preserve C-Peptide in Women with Type 1 Diabetes Mellitus
Closed-Loop Therapy and Preservation of C-Peptide Secretion in Type 1 Diabetes | NEJM
C-peptide levels at diagnosis of type 1 diabetes mellitus in both... | Download Scientific Diagram
Clinical algorithm for classification of Diabetes mellitus. Diabetes... | Download Scientific Diagram
SciELO - Brasil - Residual C-peptide in patients with Type 1 diabetes and multiethnic backgrounds Residual C-peptide in patients with Type 1 diabetes and multiethnic backgrounds
Diabetes mellitus als mögliche Spätmanifestation eines hämolytisch-urämischen Syndroms | SpringerLink
C‐peptide and the pathophysiology of microvascular complications of diabetes - Wahren - 2017 - Journal of Internal Medicine - Wiley Online Library
C-Peptide (Insulin, Proinsulin) and Interpretations - Labpedia.net
C-peptide is a bioactive peptide | SpringerLink
![PDF] Correlations between Glucagon Stimulated C-peptide Levels and Microvascular Complications in Type 2 Diabetes Patients | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/503adb20b1ee22f5d27b05496a0aad1eefbcd52f/5-Table4-1.png "PDF] Correlations between Glucagon Stimulated C-peptide Levels and Microvascular Complications in Type 2 Diabetes Patients | Semantic Scholar")
PDF] Correlations between Glucagon Stimulated C-peptide Levels and Microvascular Complications in Type 2 Diabetes Patients | Semantic Scholar
Verhältnis Proinsulin / C-Peptid mit Pathogenese assoziiert
Type of diabetes mellitus: Does it matter to the clinician? | Cleveland Clinic Journal of Medicine
Serum C-peptide concentrations poorly phenotype type 2 diabetic end-stage renal disease patients - Kidney International
Insulin micro-secretion in Type 1 diabetes and related microRNA profiles | Scientific Reports
